Kusajili – Clinical trials directory

Result of your search per sponsor: McNeil AB (Johnson & Johnson Consumer and Personal Products Worldwide, J&J CPPW)

Woman and Man Max 99 years
McNeil AB (Johnson & Johnson Consumer and Personal Products Worldwide, J&J CPPW) Update Il y a 4 ans

Efficacy and safety following use of a novel nicotine replacement therapy. A multicenter, randomized, double blind, placebo-controlled, parallel group, 52-week study in smokers motivated to quit To evaluate the efficacy of NMS versus placebo in smokers to achieve continuous abstinence from smoking from the week 2 visit until and including the week 6, week 24, and week 52 visits, respectively.

Country None
organs None
Specialty None

Closed trial

More information